Literature DB >> 6816518

Mutagenic and teratogenic effects of anti-schistosomal praziquantel.

Y C Ni, B R Shao, C Q Zhan, Y Q Xu, S H Ha, P Y Jiao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6816518

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN： 0366-6999            Impact factor:   2.628


× No keyword cloud information.
  3 in total

Review 1.  Paediatric and maternal schistosomiasis: shifting the paradigms.

Authors:  Amaya L Bustinduy; J Russell Stothard; Jennifer F Friedman
Journal:  Br Med Bull       Date:  2017-09-01       Impact factor: 4.291

2.  Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial.

Authors:  Remigio M Olveda; Luz P Acosta; Veronica Tallo; Palmera I Baltazar; Jenny Lind S Lesiguez; Georgette G Estanislao; Edna B Ayaso; Donna Bella S Monterde; Antonio Ida; Nora Watson; Emily A McDonald; Hannah W Wu; Jonathan D Kurtis; Jennifer F Friedman
Journal:  Lancet Infect Dis       Date:  2015-11-02       Impact factor: 25.071

3.  Praziquantel for the treatment of schistosomiasis during human pregnancy.

Authors:  Jennifer F Friedman; Remigio M Olveda; Mark H Mirochnick; Amaya L Bustinduy; Alison M Elliott
Journal:  Bull World Health Organ       Date:  2017-11-27       Impact factor: 9.408
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.